(TSX-V:ABI),(OTC US:ABMBF),(Other OTC:ABMBF), ROUYN-NORANDA, Quebec, Oct. 28, 2025 (GLOBE NEWSWIRE) — Abcourt Mines Inc. (“Abcourt” or the “Corporation”) (TSX Venture: ABI) (OTCQB : ABMBF) is pleased to announce the receipt of its environmental certificate of authorization for custom milling of ore from off-site deposits at its Sleeping Giant mill. This certificate of authorization allows Abcourt […]

(TSX:SJ), MONTREAL, Oct. 28, 2025 (GLOBE NEWSWIRE) — Stella-Jones Inc. (TSX: SJ) (“Stella-Jones” or the “Company”) today announced it will hold an investor day on Thursday, November 20, 2025 for institutional investors and research analysts in Toronto, Ontario. The event will begin at 9 a.m. Eastern Standard Time (EST) and is expected to conclude at

(NASDAQ:EVGO), LOS ANGELES, Oct. 28, 2025 (GLOBE NEWSWIRE) — EVgo Inc. (Nasdaq: EVGO), one of the nation's largest providers of public fast charging infrastructure for electric vehicles (EVs), today announced that it will release its third quarter 2025 financial results on Monday, November 10. This release will be followed by a webcast hosted by members

(NASDAQ:NTRB),(NASDAQ:NTRBW), Nutriband met with US FDA to obtain feedback on the Chemistry, Manufacturing, and Controls plans for AVERSA(TM) FENTANYL (abuse deterrent transdermal system) through commercialization. Nutriband received final meeting minutes from FDA and is incorporating the feedback into the development program as it moves forward to an IND filing in support of a Human Abuse

ANN ARBOR, Mich., Oct. 28, 2025 (GLOBE NEWSWIRE) — ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal disease, today announced that the first participant has been randomized in the company's Phase 2 GALAXY trial. GALAXY is a global Phase 2 clinical trial designed to evaluate

GLASGOW, Scotland, Oct. 28, 2025 (GLOBE NEWSWIRE) — Causeway Therapeutics, a clinical-stage biotechnology company developing novel medicines for tendon disease, today announced positive topline data from its Phase 2 clinical trial evaluating TenoMiR(R) (CWT-001), a proprietary microRNA-29a (miR-29a) mimic, in patients with lateral epicondylitis (commonly known as tendinopathy of the elbow or tennis elbow). Whilst

(TSX-V:KRY),(Namibian:KYX), Highlights • Assays reported for a further 17 drill holes for 5,556m of diamond drilling. • Results received are consistent and confirm mineralisation in the Target areas with Cu grades in line with and in some cases above the average mineral resource estimate (“MRE”): • Best intercepts received are as follows: • HM96: 40m

(NASDAQ:ALMU), GOLETA, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) — Aeluma, Inc. (NASDAQ: ALMU), a semiconductor company specializing in high-performance, scalable technologies for mobile, AI, defense and aerospace, robotics, automotive, AR/VR, and quantum computing, today announced that it has acquired significant capital equipment assets from a major components and solutions supplier to expand its prototyping and

Mia Syn, MS, RDN, and Nutrition Expert partners with DS Simon Media, Linear Bar, SmartyPants Vitamins, Stanley Steemer, and Reserveage at The Vitamin Shoppe NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) — This is the time of year when families are settling into school routines and cooler weather. However, it is also a perfect season

(Other OTC:CWPE),(OTC US:CWPE), Katy, Texas, Oct. 28, 2025 (GLOBE NEWSWIRE) — CW Petroleum Corp (OTCQB: CWPE) (the “Company”), a leading provider of Specialty Renewable and Hydrocarbon Motor Fuels, today announces to its investors and future investors unaudited financial results for Q3-2025. Key Financial Highlights for Three Months Ended September 30, 2025, Compared to Prior Year